Columbia Seligman Premium Technology Growth Fund Inc
Last updated September 27, 2026
Organization details
- Legal name
- Columbia Seligman Premium Technology Growth Fund Inc
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- STK
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001471420
Board of directors
-
David M. Moffett ยท DirectorSince 2024
-
Janet Carrig ยท DirectorSince 2023
-
Nancy Therese Lukitsh ยท DirectorSince 2026
-
Pamela G. Carlton ยท DirectorSince 2025
Board connections
4 of this board's directors also sit on 7 other boards.
- via David M. Moffett, Janet Carrig, Nancy Therese Lukitsh and Pamela G. Carlton
- via Pamela G. Carlton
- via David M. Moffett
- via Janet Carrig
- via Pamela G. Carlton
- via David M. Moffett
- via Janet Carrig
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $3,600
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 2025 | Pamela G. Carlton Director | Open-market purchase | +100 | $36.00 | $3,600 |
| Sep 4, 2025 | Petersen Christopher O. Officer (SVP & Asst Secretary) | Open-market sale | โ139 | $31.91 | $4,438 |
| Mar 7, 2025 | Pamela G. Carlton Director | Open-market sale | โ6 | $29.06 | $174 |
| Mar 7, 2025 | Pamela G. Carlton Director | Open-market sale | โ28 | $29.05 | $813 |
| Mar 7, 2025 | Pamela G. Carlton Director | Open-market sale | โ1,028 | $29.04 | $29,853 |
| Mar 7, 2025 | Pamela G. Carlton Director | Open-market sale | โ1 | $29.03 | $29 |
| Mar 7, 2025 | Pamela G. Carlton Director | Open-market sale | โ10 | $29.02 | $290 |
| Mar 7, 2025 | Pamela G. Carlton Director | Open-market sale | โ1 | $29.01 | $29 |
| Mar 7, 2025 | Pamela G. Carlton Director | Open-market sale | โ1,182 | $28.93 | $34,195 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.